Cargando…

Pyrotinib Sensitizes 5-Fluorouracil-Resistant HER2(+) Breast Cancer Cells to 5-Fluorouracil

5-Fluorouracil (5-FU) is a widely used chemotherapeutic agent for breast cancer. However, acquired chemoresistance leads to a loss of its efficacy; methods to reverse are urgently needed. Some studies have shown that pyrotinib, an ErbB receptor tyrosine kinase inhibitor, is effective against HER2(+)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yi, Jianing, Chen, Shuai, Yi, Pingyong, Luo, Jinlin, Fang, Meng, Du, Yang, Zou, Lianhong, Fan, Peizhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cognizant Communication Corporation 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751227/ https://www.ncbi.nlm.nih.gov/pubmed/32727638 http://dx.doi.org/10.3727/096504020X15960154585410

Ejemplares similares

53BP1 Sensitizes Breast Cancer Cells to 5-Fluorouracil
por: Li, Xiaoyan, et al.
Publicado: (2013)

Effects of the Plasma Concentration of 5‐Fluorouracil and the Duration of Continuous Venous Infusion of 5‐Fluorouracil with an Inhibitor of 5‐Fluorouracil Degradation on Yoshida Sarcomas in Rats
por: Fujii, Setsuro, et al.
Publicado: (1989)

Continuous 5-fluorouracil in the treatment of breast cancer.
por: Cameron, D. A., et al.
Publicado: (1994)

Docetaxel, cisplatin, and 5-fluorouracil compared with epirubicin, cisplatin, and 5-fluorouracil regimen for advanced gastric cancer: A systematic review and meta-analysis
por: Li, Bo, et al.
Publicado: (2019)

Hyperammonemia Secondary to 5-Fluorouracil
por: Scott, Ashley, et al.
Publicado: (2023)

GPI: An indicator for immune infiltrates and prognosis of human breast cancer from a comprehensive analysis
por: Zeng, Jie, et al.
Publicado: (2022)

Comparison of CVF (Cyclophosphamide+Vinorelbine+5-Fluorouracil) and CMF (Cyclophosphamide+Methotrexate+5-Fluorouracil) Adjuvant Chemotherapy in Early Breast Cancer
por: Gwak, Geumhee, et al.
Publicado: (2011)

5-fluorouracil-induced leukoencephalopathy in patients with breast cancer.
por: Choi, S. M., et al.
Publicado: (2001)

Spica Prunellae Extract Enhances Fluorouracil Sensitivity of 5-Fluorouracil-Resistant Human Colon Carcinoma HCT-8/5-FU Cells via TOP2α and miR-494
por: Fang, Yi, et al.
Publicado: (2019)

Up-regulation of KLF17 expression increases the sensitivity of gastric cancer to 5-fluorouracil
por: An, Zhao-jie, et al.
Publicado: (2021)

Treatment efficacy of low-dose 5-fluorouracil with ultrasound in mediating 5-fluorouracil-loaded microbubble cavitation in head and neck cancer
por: Liao, Ai-Ho, et al.
Publicado: (2022)

Bioavailability and feasibility of subcutaneous 5-fluorouracil.
por: Borner, M. M., et al.
Publicado: (1993)

5-fluorouracil and cardiotoxicity: a review
por: Sara, Jaskanwal D., et al.
Publicado: (2018)

5-Fluorouracil-induced vasospastic angina
por: Ayyildiz, Orhan, et al.
Publicado: (2005)

5-Fluorouracil Rechallenge After Cardiotoxicity
por: Desai, Aakash, et al.
Publicado: (2020)

Fluorouracil (5-FU)-induced Cardiomyopathy
por: Thalambedu, Nishanth, et al.
Publicado: (2019)

Cardiotoxicities of 5-Fluorouracil and Other Fluoropyrimidines
por: Shiga, Taro, et al.
Publicado: (2020)

5-Fluorouracil–Induced Coronary Vasospasm
por: Arya, Sumedha, et al.
Publicado: (2018)

Efficacy of 5-Fluorouracil in the Treatment of Pterygium
por: Shah, Sobia U, et al.
Publicado: (2021)

5-Fluorouracil Cardiotoxicity: Known But Unknown
por: Brell, Joanna M.
Publicado: (2021)

5-Fluorouracil Treatment Alters the Efficiency of Translational Recoding
por: Ge, Junhui, et al.
Publicado: (2017)

Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer
por: Chau, I, et al.
Publicado: (2001)

Pharmacokinetic Modulation of Plasma 5‐Fluorouracil Concentrations to Potentiate the Antitumor Activity of Continuous Venous Infusion of 5‐Fluorouracil
por: Fujii, Setsuro, et al.
Publicado: (1989)

A Comparative Study of the Efficacy of Intralesional 5 Fluorouracil vs Combination of 5 Fluorouracil with Triamcinolone Acetonide in Keloids
por: Monteiro, Rochelle C, et al.
Publicado: (2022)

Efficacy of Topical 5% 5-Fluorouracil with Needling versus 5% 5-Fluorouracil Alone in Stable Vitiligo: A Randomized Controlled Study
por: Zahra, Fatima T., et al.
Publicado: (2020)

miR-638 Serves as a Biomarker of 5-Fluorouracil Sensitivity to Neoadjuvant Chemotherapy in Breast Cancer
por: Wang, Bin, et al.
Publicado: (2022)

Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: a dose-finding study
por: Ficorella, C, et al.
Publicado: (2004)

Sinomenine sensitizes gastric cancer cells to 5-fluorouracil in vitro and in vivo
por: LIAO, FEI, et al.
Publicado: (2013)

Porokeratoma treated with topical 5% 5-fluorouracil cream
por: Li, Steve S., et al.
Publicado: (2021)

Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymes.
por: Peters, G. J., et al.
Publicado: (1989)

Pre-treatment assay of 5-fluorouracil degradation rate (5-FUDR) to improve prediction of 5-fluorouracil toxicity in gastro-esophageal cancer
por: Borro, Marina, et al.
Publicado: (2016)

Autophagy in 5-Fluorouracil Therapy in Gastrointestinal Cancer: Trends and Challenges
por: Tang, Jia-Cheng, et al.
Publicado: (2016)

Abdominal irradiation modulates 5-Fluorouracil pharmacokinetics
por: Hsieh, Chen-Hsi, et al.
Publicado: (2010)

Immune effects of 5-fluorouracil: Ambivalence matters
por: Ghiringhelli, François, et al.
Publicado: (2013)

Life-Threatening Reaction with Topical 5-Fluorouracil
por: Kishi, Patrick, et al.
Publicado: (2018)

5-Fluorouracil: Mechanisms of Resistance and Reversal Strategies
por: Zhang, Ning, et al.
Publicado: (2008)

Erythroplasia of Queyrat treated with topical 5-fluorouracil
por: Antônio, João Roberto, et al.
Publicado: (2016)

Topical 5-Fluorouracil associated skin reaction
por: Chughtai, Komal, et al.
Publicado: (2017)

Supramolecular Tripeptide Hydrogel Assembly with 5-Fluorouracil
por: Parisi, Evelina, et al.
Publicado: (2019)

Hypogeusia and hyposmia with topical 5-fluorouracil treatment
por: Gillis, Auston, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ifsnm9mp56269o5ernglkc1c1l